Technical Description
The present invention relates to a hydrogel-based formulation for sustained release of an active agent for the management of Gaucher disease.
Problems Addressed
- Complicated Process
- Multiple Drug Administration
- High Cost
- Low Biocompatibility
- Inefficient Existing Systems
Tech Features
- Glucocerebrosidase Release
- Single Drug Administration
- Neurological Symptoms Management
- Efficient Formulation
- Biocompatible
- Cost-Effective
- Selective Permeability
- Uniform Capsule
Target Audience
- Healthcare & Medical Sector
- Biotechnology Industry
- Pharmaceutical Industry
- Research & Development
Tech ID: P21-1542 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
